Skip to main content

Annovis Bio, Inc. (ANVS)

NYSEAMERICAN: ANVS · IEX Real-Time Price · USD
33.70 2.75 (8.89%)
Sep 21, 2021 3:03 PM EDT - Market open
Market Cap252.82M
Revenue (ttm)n/a
Net Income (ttm)-8.44M
Shares Out7.37M
EPS (ttm)-1.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume203,664
Open31.35
Previous Close30.95
Day's Range30.95 - 34.00
52-Week Range4.14 - 132.00
Betan/a
AnalystsBuy
Price Target150.00 (+345.1%)
Est. Earnings Daten/a

About ANVS

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. T...

IndustryBiotechnology
IPO DateJan 29, 2020
CEOMaria Maccecchini
Employees2
Stock ExchangeNYSEAMERICAN
Ticker SymbolANVS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for Annovis Bio stock is "Buy" and the 12-month stock price forecast is 150.00.

Price Target
$150.00
(345.10% upside)
Analyst Consensus: Buy

News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a L...

New York, New York--(Newsfile Corp. - September 20, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

1 day ago - Newsfile Corp

SHAREHOLDER ALERT: LIVE ANVS VIEW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered ...

Other symbols:LIVEVIEW
1 day ago - Accesswire

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Cla...

NEW YORK, Sept. 19, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and certain of its officers.

1 day ago - PRNewsWire

Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Annovis Bio, Inc. Investors of Securities Fra...

Radnor, Pennsylvania--(Newsfile Corp. - September 19, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Annovis Bio, Inc. (NYSE: ANVS) ("Annovis") that a securities fraud c...

1 day ago - Newsfile Corp

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a L...

New York, New York--(Newsfile Corp. - September 19, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

2 days ago - Newsfile Corp

Rosen, A Leading Law Firm, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important Octo...

New York, New York--(Newsfile Corp. - September 18, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE: ANVS) between May 21,...

2 days ago - Newsfile Corp

LAWSUITS FILED AGAINST ANVS, HYRE and SAM - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies ...

Other symbols:HYRESAM
4 days ago - Accesswire

CLASS ACTION UPDATE for ARDX, PHG and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sha...

NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Sharehold...

Other symbols:ARDXPHG
4 days ago - Accesswire

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Annovis Bio, Inc.

RADNOR, Pa., Sept. 15, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Annovis Bio, Inc. (NYSE: ANVS) ("Annovis") that a securities fraud class action lawsui...

5 days ago - PRNewsWire

ANVS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on B...

New York, New York--(Newsfile Corp. - September 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Annovis Bio, Inc. (NYSE American: ANVS)...

6 days ago - Newsfile Corp

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and ...

Los Angeles, California--(Newsfile Corp. - September 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc....

6 days ago - Newsfile Corp

SHAREHOLDER ALERT: Robbins LLP Announces that Annovis Bio, Inc. (ANVS) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)---- $anvs #attorney--Shareholder rights law firm Robbins LLP announces that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired...

6 days ago - Business Wire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a L...

New York, New York--(Newsfile Corp. - September 15, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

6 days ago - Newsfile Corp

ANVS INVESTOR LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Mot...

New York, New York--(Newsfile Corp. - September 14, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a se...

1 week ago - Newsfile Corp

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. ...

Los Angeles, California--(Newsfile Corp. - September 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc....

1 week ago - Newsfile Corp

SHAREHOLDER ALERT: CRMD KPLT ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / September 14, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered ...

Other symbols:CRMDKPLT
1 week ago - Accesswire

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Cla...

New York, New York--(Newsfile Corp. - September 13, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and cer...

1 week ago - Newsfile Corp

Pomerantz Law Firm Announces the Filing of a Class Action Against Annovis Bio, Inc. and Certain Officers - ANVS

NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and certain of its officers.

1 week ago - PRNewsWire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, In...

LOS ANGELES, Sept. 13, 2021 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  October 18, 2021 deadline to file a lead plaintiff motion in the class action filed on...

1 week ago - PRNewsWire

CLASS ACTION UPDATE for PLL, ZY and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Share...

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Sharehold...

Other symbols:PLLZY
1 week ago - Accesswire

CLASS ACTION UPDATE for OTLY, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sh...

NEW YORK, NY / ACCESSWIRE / September 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Sharehold...

Other symbols:OTLYSAVA
1 week ago - Accesswire

CLASS ACTION UPDATE for ATVI, YALA and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sh...

NEW YORK, NY / ACCESSWIRE / September 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Sharehold...

Other symbols:ATVIYALA
1 week ago - Accesswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a L...

New York, New York--(Newsfile Corp. - September 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

1 week ago - Newsfile Corp

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. a...

Los Angeles, California--(Newsfile Corp. - September 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc....

1 week ago - Newsfile Corp

Annovis Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BERWYN, Pa., Sept. 10, 2021 /PRNewswire/ -- Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's ...

1 week ago - PRNewsWire